---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-175515"
form_type: "8-K"
ticker: "ALXO"
cik: "0001810182"
company_name: "ALX ONCOLOGY HOLDINGS INC"
filed_at: "2022-06-16T23:59:59+00:00"
generated_at: "2026-06-25T01:22:13.059589+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# ALX Oncology annual meeting results: two directors re-elected, Say-on-Pay approved, KPMG ratified

## Summary
- Itziar Canamasas and Jack Nielsen reelected as Class II directors with 31,224,326 and 27,509,300 votes for respectively.
- Advisory Say-on-Pay proposal approved (28,566,208 for, 3,738,258 against, 8,032 abstain).
- Stockholders selected every year for frequency of future Say-on-Pay votes (32,294,203 votes for every year).
- Ratification of KPMG LLP as independent auditor for fiscal 2022 approved (34,268,632 for, 643 against, 1,668 abstain).

## SEC filing metadata
- accession: 0001193125-22-175515
- form_type: 8-K
- ticker: ALXO
- cik: 0001810182
- company_name: ALX ONCOLOGY HOLDINGS INC
- filed_at: 2022-06-16T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1810182/000119312522175515/0001193125-22-175515-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1810182/000119312522175515/d350279d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-175515
- JSON: https://secwatch.observer/filing/0001193125-22-175515.json
- Plain text: https://secwatch.observer/filing/0001193125-22-175515.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.